Searchable abstracts of presentations at key conferences in endocrinology

ea0081p596 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Transient Refractory Hyperinsulinemic Hypoglycemia

Berquist John , Wahl Matthew

Fasting hypoglycemia in the setting of hyperinsulinemia typically is persistent and often progressive. We present a case where fasting hypoglycemia with hyperinsulinemia was transient in nature over a fortnight. This occurred in the setting of recurrent seizure-like activity. Seizures are a well known sequela of hypoglycemia; however, the reverse is not nearly as well documented. A 20 year old male with a history of developmental delay, chronic PEG tube, and nonverbal at basel...

ea0070aep320 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Euglycemic DKA after initiating an SGLT-2 Inhibitor and the P90X diet

Berquist John , Kaplan Jason , Young Tessa

Introduction: We present a case of a patient with type two diabetes mellitus (T2DM) who started empagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor and the P90X diet and presented with euglycemic DKA seven days later.Case Presentation: A male in his 5th decade of life with a history of T2DM presented for a routine office appointment and had a measured hemoglobin A1C of 9.3. His home diabetes regimen consisted of metformin and sitagliptan. D...

ea0070ep123 | Bone and Calcium | ECE2020

Severe, symptomatic hypocalcemia due to denosumab and vitamin d deficiency in a post–menopausal female with osteopenia

Berquist John , Kaplan Jason , Zazaian Andrew

Denosumab is a monoclonal antibody used in the treatment of osteoporosis to prevent bony injuries by increasing bone density. It does so by binding to RANK-L, which is then unable to activate RANK, thereby preventing osteoclast maturation and viability. Although rare, the effect of denosumab can interfere with the body’s calcium homeostasis and lead to a hypocalcemic state. We present a case where a post-menopausal female developed severe, symptomatic hypocalcemia from a...